24,191 Liquidia Corporation $LQDA Shares Sold by Signaturefd LLC

Signaturefd LLC lessened its stake in Liquidia Corporation (NASDAQ:LQDA) by 79.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 6,119 shares of the company’s stock after selling 24,191 shares during the period. Signaturefd LLC’s holdings in Liquidia were worth $185,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Sterling Capital Management LLC boosted its stake in Liquidia by 839.1% during the 3rd quarter. Sterling Capital Management LLC now owns 2,329 shares of the company’s stock valued at $70,000 after acquiring an additional 2,081 shares during the last quarter. Yousif Capital Management LLC grew its holdings in Liquidia by 4.1% during the 3rd quarter. Yousif Capital Management LLC now owns 20,008 shares of the company’s stock worth $605,000 after acquiring an additional 794 shares in the last quarter. Nisa Investment Advisors LLC grew its holdings in Liquidia by 13.8% during the 3rd quarter. Nisa Investment Advisors LLC now owns 2,634 shares of the company’s stock worth $80,000 after acquiring an additional 320 shares in the last quarter. WINTON GROUP Ltd bought a new stake in shares of Liquidia in the 2nd quarter worth about $335,000. Finally, Arizona State Retirement System increased its position in shares of Liquidia by 5.4% in the 2nd quarter. Arizona State Retirement System now owns 17,627 shares of the company’s stock worth $1,405,000 after purchasing an additional 900 shares during the last quarter. Institutional investors own 64.54% of the company’s stock.

Insider Buying and Selling at Liquidia

In other Liquidia news, Director Stephen M. Bloch sold 235,477 shares of the stock in a transaction on Monday, October 5th. The stock was sold at an average price of $27.13, for a total value of $6,388,491.01. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Roger Jeffs sold 32,744 shares of the firm’s stock in a transaction on Monday, October 12th. The shares were sold at an average price of $28.48, for a total value of $932,549.12. Following the completion of the sale, the chief executive officer owned 1,125,848 shares in the company, valued at $32,064,151.04. The trade was a 2.83% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders have sold 566,579 shares of company stock worth $25,746,120. 25.60% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on LQDA shares. Jefferies Financial Group upgraded shares of Liquidia to a “strong-buy” rating in a research note on Thursday, October 1st. Needham & Company LLC decreased their price target on Liquidia from $72.00 to $58.00 and set a “buy” rating for the company in a research note on Wednesday, October 14th. HC Wainwright boosted their price objective on Liquidia from $58.00 to $65.00 and gave the company a “buy” rating in a report on Thursday, October 15th. Weiss Ratings raised Liquidia from a “sell (d-)” rating to a “hold (c)” rating in a report on Tuesday, September 22nd. Finally, Wells Fargo & Company upped their price objective on Liquidia from $30.00 to $33.00 and gave the company an “equal weight” rating in a research note on Wednesday, October 14th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, four have assigned a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, Liquidia has an average rating of “Hold” and a consensus target price of $72.85.

Liquidia Stock Down 7.1%

LQDA stock opened at $41.85 on Tuesday. The firm has a market cap of $3.75 billion, a price-to-earnings ratio of 33.37, a PEG ratio of 0.40 and a beta of 0.61. Liquidia Corporation has a 1-year low of $22.21 and a 1-year high of $93.61. The firm has a fifty day moving average price of $52.46 and a two-hundred day moving average price of $54.32. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.31 and a quick ratio of 2.12.

Liquidia (NASDAQ:LQDA) last posted its quarterly earnings results on Wednesday, August 12th. The company reported $0.74 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.02). Liquidia had a return on equity of 149.65% and a net margin of 30.74%. The business had revenue of $171.68 million during the quarter, compared to the consensus estimate of $168.48 million. During the same quarter in the previous year, the business posted ($0.49) earnings per share. The company’s quarterly revenue was up 1842.1% compared to the same quarter last year. Research analysts predict that Liquidia Corporation will post 2.05 EPS for the current year.

Liquidia Company Profile

Liquidia Corporation is a biopharmaceutical company focused on developing and commercializing therapies for patients with pulmonary hypertension and other serious cardiopulmonary diseases. The company is headquartered in Research Triangle Park, North Carolina, and uses its proprietary PRINT technology to engineer drug particles with controlled size, shape and composition for inhaled and injectable medicines.

Liquidia’s lead product is Yutrepia (treprostinil) inhalation powder, a dry-powder formulation of treprostinil delivered through a proprietary inhaler.